Quality Assessment in Acute Stroke Care (QuASt)

January 12, 2010 updated by: University Hospital Muenster

Quality of Acute Stroke Care Evaluated With a Clinical Pathway on a 16 Bed Stroke Unit - a Prospective Trial

The purpose of the study is to evaluate the quality of care on a 16 bed stroke unit by using a new developed clinical pathway.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
      • Muenster, Germany, 48149
        • Recruiting
        • Department of neurology, University Hospital of Muenster
        • Contact:
        • Sub-Investigator:
          • Christoffer Kraemer, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with an acute ischemic stroke admitted to the stroke unit of the university hospital in Muenster, Germany

Description

Inclusion Criteria:

  • admission to the stroke unit of the university hospital in Muenster, Germany
  • acute ischemic stroke or transient ischemic attack

Exclusion Criteria:

  • intracerebral haemorrhage
  • neurological symptoms due to other pathology than acute ischemic stroke or transient ischemic attack
  • intraarterial thrombolysis
  • necessity of artificial ventilation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
frequency of patients monitored according to the specific german procedure standard (OPS-code 8-981) (preset target 90 - 95 %)
Time Frame: duration of stay on stroke unit
duration of stay on stroke unit

Secondary Outcome Measures

Outcome Measure
Time Frame
frequency of stroke been classified according to the TOAST criteria (preset target 55 - 65 %)
Time Frame: duration of stay on stroke unit
duration of stay on stroke unit
frequency of initiated or improved antithrombotic secondary prevention (preset target 90 - 95 %)
Time Frame: duration of stay on stroke unit
duration of stay on stroke unit
frequency of initiated or improved statin therapy (preset target 40 - 50 %)
Time Frame: duration of stay on stroke unit
duration of stay on stroke unit
frequency of totally completed clinical diagnostics regarding the etiology of the stroke (preset target 60 -70 %)
Time Frame: duration of stay on stroke unit
duration of stay on stroke unit
frequency of initiated or improved antihypertension therapy and reduction of systolic and diastolic blood pressure by more than 10 mmHg (preset target 60 - 70 %)
Time Frame: duration of stay on stroke unit
duration of stay on stroke unit
frequency of a reduction on the NIH-SS by at least two points (preset target 50 - 60 %)
Time Frame: duration of stay on stroke unit
duration of stay on stroke unit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital Muenster

Investigators

  • Principal Investigator: Wolf Rüdiger Schäbitz, MD, Department of Neurology, University Hospital of Muenster, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2007

Study Completion (Anticipated)

April 1, 2009

Study Registration Dates

First Submitted

November 23, 2007

First Submitted That Met QC Criteria

December 14, 2007

First Posted (Estimate)

December 17, 2007

Study Record Updates

Last Update Posted (Estimate)

January 13, 2010

Last Update Submitted That Met QC Criteria

January 12, 2010

Last Verified

November 1, 2007

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ClinPathStroke

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Ischemic Stroke

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe